BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8198977)

  • 1. Case-control study of gastric cancer screening in Venezuela.
    Pisani P; Oliver WE; Parkin DM; Alvarez N; Vivas J
    Br J Cancer; 1994 Jun; 69(6):1102-5. PubMed ID: 8198977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of the Korean National Cancer Screening Program in Reducing Gastric Cancer Mortality.
    Jun JK; Choi KS; Lee HY; Suh M; Park B; Song SH; Jung KW; Lee CW; Choi IJ; Park EC; Lee D
    Gastroenterology; 2017 May; 152(6):1319-1328.e7. PubMed ID: 28147224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epidemiological evaluation of the protective effect for dying of stomach cancer by screening programme for stomach cancer with applying a method of case-control study--a study of a efficient screening programme for stomach cancer].
    Abe Y; Mitsushima T; Nagatani K; Ikuma H; Minamihara Y
    Nihon Shokakibyo Gakkai Zasshi; 1995 May; 92(5):836-45. PubMed ID: 7783375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a mass screening program for stomach cancer with a case-control study design.
    Oshima A; Hirata N; Ubukata T; Umeda K; Fujimoto I
    Int J Cancer; 1986 Dec; 38(6):829-33. PubMed ID: 3793262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evaluation of screening for gastric cancer in Miyagi Prefecture, Japan: a population-based case-control study.
    Fukao A; Tsubono Y; Tsuji I; HIsamichi S; Sugahara N; Takano A
    Int J Cancer; 1995 Jan; 60(1):45-8. PubMed ID: 7814150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric cancer screening and subsequent risk of gastric cancer: a large-scale population-based cohort study, with a 13-year follow-up in Japan.
    Lee KJ; Inoue M; Otani T; Iwasaki M; Sasazuki S; Tsugane S;
    Int J Cancer; 2006 May; 118(9):2315-21. PubMed ID: 16331632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of validity of mass screening program for gastric cancer in Osaka, Japan.
    Murakami R; Tsukuma H; Ubukata T; Nakanishi K; Fujimoto I; Kawashima T; Yamazaki H; Oshima A
    Cancer; 1990 Mar; 65(5):1255-60. PubMed ID: 2302674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower risk of death from gastric cancer among participants of gastric cancer screening in Japan: a population-based cohort study.
    Miyamoto A; Kuriyama S; Nishino Y; Tsubono Y; Nakaya N; Ohmori K; Kurashima K; Shibuya D; Tsuji I
    Prev Med; 2007 Jan; 44(1):12-9. PubMed ID: 16956654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of endoscopic gastric cancer screening in a rural area of Linzhou, China: results from a case-control study.
    Chen Q; Yu L; Hao CQ; Wang JW; Liu SZ; Zhang M; Zhang SK; Guo LW; Quan PL; Zhao N; Zhang YW; Sun XB
    Cancer Med; 2016 Sep; 5(9):2615-22. PubMed ID: 27367362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A community-based, case-control study evaluating mortality reduction from gastric cancer by endoscopic screening in Japan.
    Hamashima C; Ogoshi K; Okamoto M; Shabana M; Kishimoto T; Fukao A
    PLoS One; 2013; 8(11):e79088. PubMed ID: 24236091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of mass screening program for stomach cancer.
    Hisamichi S; Nozaki K; Kitagawa M; Mochizuki F; Gomi T
    Tohoku J Exp Med; 1976; 118 Suppl():69-77. PubMed ID: 964032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The usefulness of gastric mass screening using serum pepsinogen levels compared with photofluorography.
    Yoshihara M; Sumii K; Haruma K; Kiyohira K; Hattori N; Tanaka S; Kajiyama G; Shigenobu T
    Hiroshima J Med Sci; 1997 Jun; 46(2):81-6. PubMed ID: 9232936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of colorectal cancer screening: results from a population-based case-control evaluation in Saarland, Germany.
    Wahrendorf J; Robra BP; Wiebelt H; Oberhausen R; Weiland M; Dhom G
    Eur J Cancer Prev; 1993 May; 2(3):221-7. PubMed ID: 8490540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors and clinical outcomes of gastric cancer identified by screening endoscopy: a case-control study.
    Gong EJ; Ahn JY; Jung HY; Lim H; Choi KS; Lee JH; Kim DH; Choi KD; Song HJ; Lee GH; Kim JH; Choi SY; Choe JW; Kim MJ
    J Gastroenterol Hepatol; 2014 Feb; 29(2):301-9. PubMed ID: 24117845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salt-preserved foods and risk of gastric cancer.
    Strumylaite L; Zickute J; Dudzevicius J; Dregval L
    Medicina (Kaunas); 2006; 42(2):164-70. PubMed ID: 16528133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case-control study to evaluate efficacy of screening for faecal occult blood.
    Lazovich D; Weiss NS; Stevens NG; White E; McKnight B; Wagner EH
    J Med Screen; 1995; 2(2):84-9. PubMed ID: 7497161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of gastric mass screening in Japan.
    Hisamichi S; Sugawara N; Fukao A
    Cancer Detect Prev; 1988; 11(3-6):323-9. PubMed ID: 3390854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammography screening and risk of breast cancer death: a population-based case-control study.
    Otto SJ; Fracheboud J; Verbeek AL; Boer R; Reijerink-Verheij JC; Otten JD; Broeders MJ; de Koning HJ;
    Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):66-73. PubMed ID: 22147362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of endoscopic screening in an isolated island: a case-control study.
    Matsumoto S; Yoshida Y
    Indian J Gastroenterol; 2014 Jan; 33(1):46-9. PubMed ID: 23996741
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.